Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

SCORTEN overestimates mortality in the setting of a standardized treatment protocol.

Journal of burn care & research : official publication of the American Burn Association

Survival Analysis, Adult, mortality, etiology, classification, Stevens-Johnson Syndrome, adverse effects, Steroids, Severity of Illness Index, Retrospective Studies, Middle Aged, Male, Infant, Humans, Female, Anticonvulsants, Anti-Bacterial Agents, Aged, 80 and over, Age Factors

Read this article at

ScienceOpenPublisherPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      Toxic epidermal necrolysis (TEN) is a rare, severe, exfoliative disorder with a high mortality rate. SCORTEN is a recently developed scoring system that estimates severity and predicts mortality in patients with TEN based on seven independent clinical risk factors recorded within the first 24 hours of admission. An increasing SCORTEN level predicts a higher mortality rate. For more than 20 years, the treatment of TEN at our institution has involved the use of a standardized clinical pathway that includes removal of sloughed epidermis, dermal protection with porcine xenograft, early enteral nutrition, and critical care monitoring. We hypothesize that this standardized clinical approach will result in a lower mortality rate than predicted by SCORTEN. A retrospective review was performed on all patients treated for TEN using the standardized pathway from February 1987 to March 2004. SCORTEN was calculated in each patient. One hundred nine patients were treated for TEN during the study period. Overall observed mortality was 20% compared with a SCORTEN predicted mortality of 30%, resulting in a relative reduction in mortality of 33% (P = .011). In addition, observed probability of death was lower than predicted at all levels, except at SCORTEN score of 6 or greater. In conclusion, TEN remains a life-threatening disease with a high mortality rate. Our standardized treatment protocol results in significantly improved outcomes compared to those predicted by SCORTEN.

      Related collections

      Author and article information

      Journal
      10.1097/01.BCR.0000216532.71360.9B
      16679892

      Comments

      Comment on this article